The war on AIDS has been going on since the late 1980s. Doctors have tried numerous treatments, the main approach being to find a drug or outside remedy to help the immune system fight off the anti-immune virus. However, recent discoveries have found that the key to helping the immune system fight AIDS may actually lie within the immune system itself.
Scientists have reported finding special antibodies in the immune system that have been shown to fight off over ninety percent of the HIV-1 strain, and that even includes some major genetic subtypes as well. While it still may be a few years before an HIV vaccine from these medical findings can be developed, the news is very encouraging. The key to developing an actual HIV vaccine is figuring out why the special antibodies are only present in some people.
Antibodies help the immune system to prevent infection. Usually antibodies are able to bind with germs in order to disable them. With the HIV virus, the virus is constantly adjusting itself in order to avoid antibody detection, so the antibodies are playing a constant catch-up game with the virus. In the recent studies, three antibodies seem to have a lot of power over the HIV virus. Scientists are exploring how this is, and what kind of vaccines would be possible from these findings.
Image Credit: <a rel="nofollow" href="http://himachal.us/category/festivals">my himachal</a> | <a rel="nofollow" href="http://www.american.com/archive/2008/february-02-08/how-not-to-win-the-fight-against-aids/">the american</a> | <a rel="nofollow" href="http://www.stanford.edu/group/virus/retro/2005gongishmail/HIV.html">stanford</a>
What's Driving This Trend
- Antibody-based Treatments
- The discovery of special antibodies that fight HIV could lead to antibody-based treatments for the virus.
- Vaccine Development
- Understanding how the special antibodies work could lead to the development of an HIV vaccine.
- Immunotherapy Advancements
- The use of antibodies in the immune system to fight diseases like HIV could lead to advancements in immunotherapy.
Who This Affects Most
- Pharmaceuticals
- Pharmaceutical companies could utilize these findings to develop antibody-based treatments and vaccines for HIV.
- Biotechnology
- Biotech companies could use this research to advance immunotherapy and antibody-based treatments for a range of diseases.
- Healthcare
- The discovery of these antibodies could significantly impact the healthcare industry with the potential to create new treatments and vaccines for HIV.
